IN2012DN02195A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02195A IN2012DN02195A IN2195DEN2012A IN2012DN02195A IN 2012DN02195 A IN2012DN02195 A IN 2012DN02195A IN 2195DEN2012 A IN2195DEN2012 A IN 2195DEN2012A IN 2012DN02195 A IN2012DN02195 A IN 2012DN02195A
- Authority
- IN
- India
- Prior art keywords
- administering
- alone
- subject
- effective amount
- therapeutically effective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24364809P | 2009-09-18 | 2009-09-18 | |
| PCT/US2010/048314 WO2011034775A2 (fr) | 2009-09-18 | 2010-09-09 | Méthodes de traitement de tumeurs cérébrales |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN02195A true IN2012DN02195A (fr) | 2015-08-21 |
Family
ID=43756836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2195DEN2012 IN2012DN02195A (fr) | 2009-09-18 | 2010-09-09 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20110070314A1 (fr) |
| EP (1) | EP2477635A4 (fr) |
| JP (1) | JP2013505242A (fr) |
| KR (1) | KR20120048706A (fr) |
| CN (1) | CN102753188A (fr) |
| AR (1) | AR078170A1 (fr) |
| AU (1) | AU2010295841A1 (fr) |
| BR (1) | BR112012008310A2 (fr) |
| CA (1) | CA2772777A1 (fr) |
| IN (1) | IN2012DN02195A (fr) |
| MX (1) | MX2012002922A (fr) |
| RU (1) | RU2012108439A (fr) |
| SG (1) | SG179192A1 (fr) |
| TW (1) | TW201114431A (fr) |
| WO (1) | WO2011034775A2 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG179069A1 (en) * | 2009-09-10 | 2012-04-27 | Kominox Inc | Cancer stem cell-targeted and drug resistant cancer therapy |
| KR101309036B1 (ko) * | 2011-05-30 | 2013-09-16 | 주식회사 코미팜 | 방사선 민감도 증진용 약학 조성물 |
| US8781202B2 (en) * | 2012-07-26 | 2014-07-15 | International Business Machines Corporation | Tumor classification based on an analysis of a related ultrasonic attenuation map |
| US10076652B2 (en) * | 2015-08-10 | 2018-09-18 | Chang Gung University | Method for ultrasound-mediated delivery system to monitor molecular penetration |
| EP3768247A4 (fr) * | 2018-03-22 | 2021-12-29 | Komipharm International Australia Pty Ltd | Composition pharmaceutique comprenant du méta-arsénite et procédé de fabrication |
| KR20220020635A (ko) * | 2020-08-12 | 2022-02-21 | 이상봉 | 탈모방지 또는 발모촉진용 외용제 조성물 |
| KR20220020637A (ko) * | 2020-08-12 | 2022-02-21 | 이상봉 | 항암화학요법이나 방사선요법으로 인한 암 환자의 탈모증을 포함한 탈모증 환자에 대하여 탈모를 방지하고 발모를 촉진하는 메타아르세나이트의 염을 함유하는 경구 투여용 약학적 조성물 |
| KR20220020633A (ko) * | 2020-08-12 | 2022-02-21 | 이상봉 | 탈모방지 또는 발모촉진용 주사제 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1419778A1 (fr) * | 1997-10-15 | 2004-05-19 | Polarx Biopharmaceuticals, Inc. | Compositions et méthodes de traitement de maladies néoplasiques primitives et métastatiques à l'aide de composés d'arsenic |
| KR20020083678A (ko) * | 2001-04-28 | 2002-11-04 | 주식회사 한국미생물연구소 | 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물 |
| ES2425418T3 (es) * | 2002-04-10 | 2013-10-15 | Komipharm International Co., Ltd. | Composición farmacéutica que comprende arsenito para el tratamiento de neoplasias |
| WO2006104292A1 (fr) * | 2005-03-31 | 2006-10-05 | Komipharm International Co., Ltd. | Composition pharmaceutique qui comprend de l’acide arsénique, du meta-arsénite et des sels pharmaceutiquement acceptables |
| EP1721615A1 (fr) * | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Composition pharmaceutique comprenant de l'arsenite de sodium ou de potassium pour traiter le cancer urogenital et ses métastases |
-
2010
- 2010-09-09 BR BR112012008310A patent/BR112012008310A2/pt not_active IP Right Cessation
- 2010-09-09 IN IN2195DEN2012 patent/IN2012DN02195A/en unknown
- 2010-09-09 SG SG2012018859A patent/SG179192A1/en unknown
- 2010-09-09 CN CN2010800414064A patent/CN102753188A/zh active Pending
- 2010-09-09 MX MX2012002922A patent/MX2012002922A/es not_active Application Discontinuation
- 2010-09-09 AU AU2010295841A patent/AU2010295841A1/en not_active Abandoned
- 2010-09-09 EP EP10817682A patent/EP2477635A4/fr not_active Withdrawn
- 2010-09-09 JP JP2012529803A patent/JP2013505242A/ja not_active Withdrawn
- 2010-09-09 CA CA2772777A patent/CA2772777A1/fr not_active Abandoned
- 2010-09-09 WO PCT/US2010/048314 patent/WO2011034775A2/fr active Application Filing
- 2010-09-09 KR KR1020127008137A patent/KR20120048706A/ko not_active Application Discontinuation
- 2010-09-09 RU RU2012108439/15A patent/RU2012108439A/ru not_active Application Discontinuation
- 2010-09-10 US US12/879,316 patent/US20110070314A1/en not_active Abandoned
- 2010-09-10 TW TW099130699A patent/TW201114431A/zh unknown
- 2010-09-10 AR ARP100103326A patent/AR078170A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2477635A4 (fr) | 2013-03-27 |
| US20110070314A1 (en) | 2011-03-24 |
| RU2012108439A (ru) | 2013-10-27 |
| MX2012002922A (es) | 2012-09-07 |
| JP2013505242A (ja) | 2013-02-14 |
| AU2010295841A1 (en) | 2012-03-29 |
| EP2477635A2 (fr) | 2012-07-25 |
| BR112012008310A2 (pt) | 2017-06-06 |
| TW201114431A (en) | 2011-05-01 |
| WO2011034775A2 (fr) | 2011-03-24 |
| SG179192A1 (en) | 2012-05-30 |
| CA2772777A1 (fr) | 2011-03-24 |
| WO2011034775A3 (fr) | 2011-10-06 |
| CN102753188A (zh) | 2012-10-24 |
| KR20120048706A (ko) | 2012-05-15 |
| AR078170A1 (es) | 2011-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02195A (fr) | ||
| AU2011328009A8 (en) | Compounds and methods for treating pain | |
| MX2013003076A (es) | Terapeuticos contra cancer de mama. | |
| TN2013000227A1 (en) | Use of sigma ligands in bone cancer pain | |
| UA115122C2 (uk) | Cd3-зв'язувальна молекула, здатна до зв'язування з cd3 людини і cd3, що не є людським | |
| MX348566B (es) | Tratamiento del cáncer con inhibidores de tor cinasa. | |
| EP3722810A3 (fr) | Profilage moléculaire de tumeurs | |
| MX2011008221A (es) | Tratamiento de cancer de pulmon con un compuesto de nitrobenzamida en combinacion con un inhibidor de un factor de crecimieno. | |
| EP2294184A4 (fr) | Traitement de maladies oculaires et d une néovascularisation excessive utilisant un traitement combiné | |
| EP2582682A4 (fr) | Procédés pour traiter une affection pulmonaire | |
| MX2020010004A (es) | Composicion farmaceutica que comprende empagliflozina, metodos para tratamiento y sus usos. | |
| MY191932A (en) | Chitosan-derived compositions | |
| PH12015501002A1 (en) | Treatment of cancer with pomalidomide in a renally impaired subject | |
| PH12015500169A1 (en) | Prediction of treatment response to jak/stat inhibitor | |
| PH12015500867B1 (en) | Treatment of prostate cancer with tor kinase inhibitors | |
| SG191060A1 (en) | Robo1-fc fusion protein for use in the treatment of hepatocarcinoma | |
| MD4629B1 (ro) | Metode de tratament a fibrozei şi cancerului | |
| MX2011008994A (es) | Metodos de usar sns - 595 para el tratamiento de sujetos con cancer con actividad reducida de brca2. | |
| WO2014071168A3 (fr) | Administration d'inhibiteurs de la signalisation tgfbêta, dérivés de benzothiazépine ou combinaisons de ceux-ci pour améliorer la fonction musculaire chez des patients cancéreux | |
| SG179069A1 (en) | Cancer stem cell-targeted and drug resistant cancer therapy | |
| NZ701974A (en) | Novel therapeutic treatments with anti-her2 antibodies having a low fucosylation | |
| PH12015501113A1 (en) | Combination therapy with volasertib | |
| MX2016001084A (es) | Volasertib en combinacion con decitabina para el tratamiento de leucemia mieloide aguda y sindrome mielodisplasico. | |
| MX357770B (es) | Ácidos nucleicos de enlace sdf-1 y el uso de los mismos en el tratamiento de cáncer. | |
| MX2016001087A (es) | Volasertib en combinacion con azacitidina para el tratamiento de leucemia mieloide aguda y sindrome mielodisplasico. |